[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.90.95. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
October 1987

Metallothionein Gene Regulation in Menkes' Syndrome

Author Affiliations

From the Laboratory of Biochemistry, National Cancer Institute, National Institutes of Health, Bethesda, Md.

Arch Dermatol. 1987;123(10):1384a-1385a. doi:10.1001/archderm.1987.01660340156039
Abstract

• The characteristic feature of Menkes' disease is a maldistribution of bodily copper; decreased copper levels are present in the serum, brain, and liver, whereas excess levels are present in gut, kidney, and most other nonhepatic tissues. Using cultured fibroblasts, we have shown that low extracellular copper concentrations induce synthesis of metallothionein, a copper-binding protein, in Menkes' cells but not in normal cells. This is due to a defect in a diffusable regulatory factor that is probably involved in copper metabolism. To further understand the role of the defective factor in transcription, assays have been developed to study the metaldependent binding of nuclear proteins to metallothionein gene control sequences.

(Arch Dermatol 1987;123:1384a-1385a)

×